CB

Camille Bedrosian

AP Alexion Pharmaceuticals: 5 patents #26 of 226Top 15%
GI Genetics Institute: 2 patents #135 of 327Top 45%
Pfizer: 1 patents #3,022 of 5,153Top 60%
📍 Woodbridge, CT: #56 of 239 inventorsTop 25%
🗺 Connecticut: #5,660 of 34,797 inventorsTop 20%
Overall (All Time): #624,161 of 4,157,543Top 20%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
11459382 Dosage and administration of anti-C5 antibodies for treatment of protein-losing enteropathy in patients Orly Eshach Adiv, Hagit Baris Feldman, Alina Kurolap, Susan Faas McKnight 2022-10-04
11244744 Risk evaluation and management strategy involving patient follow-ups relating to the use or discontinuation of a complement inhibitor Leonard Bell 2022-02-08
11031102 Risk evaluation and management strategy involving patient follow-ups relating to the use or discontinuation of a complement inhibitor Leonard Bell 2021-06-08
9771418 Methods for treating complement-associated disorders Russell P. Rother, Stephen P. Squinto, Leonard Bell 2017-09-26
9447176 Methods and compositions for treating complement-associated disorders Russell P. Rother, Stephen P. Squinto, Leonard Bell 2016-09-20
6887461 Method of using IL-11 for treating mucositis Nick W. Warne, James Keith, Ullrich S. Schwertschlag, Paul Schendel 2005-05-03
6540993 Method of treating inflammatory bowel disease using a topical formulation of IL-11 Nicholas W. Warne, James Keith, Ullrich S. Schwerschlag, Paul Schendel 2003-04-01
6126933 Methods of treating inflammatory bowel diseases by administering IL-11 Nick W. Warne, James Keith, Ullrich S. Schwertschlag, Paul Schendel 2000-10-03